Hargreaves, IP and Mantle, D (2021) COVID-19, Coenzyme Q10 and Selenium. In: Identification of Biomarkers, New Treatments, and Vaccines for COVID-19. Advances in Experimental Medicine and Biology, 1327 . Springer, pp. 161-168. ISBN 978-3-030-71696-7

Text COVID-19, Coenzyme Q10 and Selenium.pdf - Accepted Version Restricted to Repository staff only until 20 July 2023. Download (383kB)

Abstract

In COVID-19 infection, a balance must be achieved in immune defence against the virus without precipitating a cytokine storm, which is responsible for lung injury and respiratory distress in severe cases. The initial immune response and the subsequent resolution of inflammation are likely to be dependent on nutritional status, as one contributing factor. Here, we have reviewed the potential link between two specific nutrients, coenzyme Q10 (CoQ10) and selenium, with effects on oxidative stress and inflammation in viral infection. We conclude that both reagents show promise in the treatment of patients with COVID-19 disease. This could give particular relevance over the next several months as promising vaccines are deployed to minimise the COVID-19 spread and as a potential preventative or mitigating approach for future epidemics and pandemics

Item Type:	Book Section
Subjects:	R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Divisions:	Pharmacy & Biomolecular Sciences
Publisher:	Springer
Date Deposited:	21 Jul 2021 08:28
Last Modified:	16 Mar 2023 11:47
DOI or Identification number:	10.1007/978-3-030-71697-4_13
URI:	https://researchonline.ljmu.ac.uk/id/eprint/15308

Actions (login required)

View Item